|
2007P-0030:
ANDA Suitability for Acetaminophen 400 mg, Butalbital 50 mg and
Caffeine 40 mg Capsules
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 01/22/2007
|
| 01/22/2007
|
| Private Industry
|
| Lachman Consultant
Services, Inc.
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Robert W. Pollock
|
|
|
|
|
| ACK1
|
| 01/22/2007
|
| 01/22/2007
|
| Federal Government
|
| FDA/ DDM to Lachman
Consultant Services, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Gloria Ortega
|
|
|
|
Top
| Up
Page last updated:
April 6, 2007
|
